Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3957967012 | Glucosamine sulfate potassium chloride | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3957968019 | Glucosamine sulfate potassium chloride (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glucosamine sulfate potassium chloride | Is modification of (attribute) | Glucosamine | true | Inferred relationship | Some | ||
| Glucosamine sulfate potassium chloride | Is a | Amino sugar | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely glucosamine (as glucosamine sulfate potassium chloride) 400 milligram/1 each conventional release oral capsule (clinical drug) | Has precise active ingredient | True | Glucosamine sulfate potassium chloride | Inferred relationship | Some | 1 |
| Product containing precisely diacerein 50 milligram and glucosamine sulfate potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | True | Glucosamine sulfate potassium chloride | Inferred relationship | Some | 2 |
| Product containing precisely diacerein 50 milligram and glucosamine sulfate potassium chloride 1.5 gram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | True | Glucosamine sulfate potassium chloride | Inferred relationship | Some | 2 |
This concept is not in any reference sets
FHIR